# Embracing Anti-Fragility in Pharma Manufacturing

This white paper examines the transformative role of Mareana CPV (Continued Process Verification) in pharmaceutical manufacturing, emphasizing its unparalleled ability to enhance antifragility in operations.

### Complete the form below to Download the White Paper.

## Related White Papers

[Oversight Without Control: A guide for Virtual Pharma Manufacturers](/content/whitepaper/oversight-without-control-guide-for-virtual-pharma/index.html)

[Revolutionizing Batch Release: Leveraging AI to Enhance Compliance and Streamline Operations in Manufacturing](/content/whitepaper/revolutionizing-batch-release-to-enhance-compliance-and-streamline-operations/index.html)

[Leveraging Mareana to Implement Process Analytical Tools (PAT) for Enhanced Pharmaceutical Manufacturing](/content/whitepaper/leveraging-connect-cpv-to-implement-process-analytical-tools-pat-for-enhanced-pharmaceutical-manufacturing/index.html)

## Stay Ahead with Mareana™

Take your pharmaceutical manufacturing to the digital age with an AI-driven platform that empowers you to Make Confidently, Release Confidently, and Comply Confidently.

[Speak to an Expert](/content/contact-us/index.html)